Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease.

[1]  S. Solomon,et al.  Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. , 2012, JAMA.

[2]  S. Solomon,et al.  Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. , 2011, American heart journal.

[3]  P. Kang,et al.  Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. , 2011, Cardiovascular research.

[4]  I. Kubota,et al.  Increased left atrial volume index predicts a poor prognosis in patients with heart failure. , 2011, Journal of cardiac failure.

[5]  W. März,et al.  Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients , 2010, European heart journal.

[6]  Rajan K. Patel,et al.  Association of Left Atrial Volume With Mortality Among ESRD Patients With Left Ventricular Hypertrophy Referred for Kidney Transplantation , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  A. Ng,et al.  Prognostic implications of left atrial volume index in patients in sinus rhythm. , 2010, The American journal of cardiology.

[8]  D. Whellan,et al.  Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). , 2008, The American journal of cardiology.

[9]  H. Uno,et al.  Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. , 2008, European heart journal.

[10]  M. Whooley,et al.  Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). , 2008, The American journal of cardiology.

[11]  D. Tishkoff,et al.  Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. , 2008, Endocrinology.

[12]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[13]  N. Bodyak,et al.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.

[14]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[15]  S. Chen,et al.  Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells. , 2007, Kidney international.

[16]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[17]  Salahuddin Ahmed,et al.  Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[18]  R. Devereux,et al.  Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial , 2007, Hypertension.

[19]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[20]  C. Zoccali,et al.  Left atrial volume in end-stage renal disease: a prospective cohort study , 2006, Journal of hypertension.

[21]  S. Solomon,et al.  A clinician's guide to tissue Doppler imaging. , 2006, Circulation.

[22]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  J. Singer,et al.  Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  D. Gardner,et al.  1,25 dihydroxyvitamin d amplifies type a natriuretic peptide receptor expression and activity in target cells. , 2005, Journal of the American Society of Nephrology : JASN.

[25]  M. Komajda,et al.  Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. , 2004, European heart journal.

[26]  James B Seward,et al.  Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. , 2002, The American journal of cardiology.

[27]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[28]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[29]  M. Quiñones,et al.  Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. , 2000, Journal of the American College of Cardiology.

[30]  M. Haussler,et al.  Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains. , 1998, Hypertension.

[31]  J. Wu,et al.  1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. , 1996, The Journal of clinical investigation.

[32]  R B D'Agostino,et al.  Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.

[33]  D. Gardner,et al.  Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3. , 1994, The Journal of biological chemistry.

[34]  C. Appleton,et al.  Pulmonary venous flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume, and ejection fraction. , 1991, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[35]  A. Labovitz,et al.  Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. , 1991, Journal of the American College of Cardiology.

[36]  R. O'rourke,et al.  Left atrial enlargement: an early sign of hypertensive heart disease. , 1988, American heart journal.

[37]  J. Frøkiaer,et al.  Reduced expression of Na-K-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats. , 2002, American journal of physiology. Renal physiology.

[38]  S. Kaul,et al.  Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. , 1995, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.